CGT Global

CGT Global is a biotechnology company based in Folsom, California. The company employs 25 individuals and generates $50 million in annual revenue. Founded in 2010, CGT Global is dedicated to accelerating the development and implementation of treatments for significant medical conditions. CGT Global specializes in providing biospecimens, including human primary cells, stem cells, bone marrow, cord blood, peripheral blood, maternal blood, and disease-specific products. These biospecimens are supplied to a variety of clients, such as academic institutions, biotechnology companies, diagnostic laboratories, pharmaceutical organizations, and contract research organizations. The company operates four FDA-registered collection centers across the United States, each equipped with state-of-the-art cell manufacturing laboratories for both clinical and research purposes. In addition, CGT Global offers CLIA certified/high-complexity diagnostic services. For more information about CGT Global and its services, visit their website at cgt.global.